Clinical Trials in Michigan

Showing 13461-13480 of 16,154 trials

Depression Screening in Patients Undergoing Radiation Therapy For Cancer

NCT00951184

RATIONALE: Gathering information about depression in patients with cancer may help doctors learn more about the disease and plan the best treatment. PURPOSE: This clinical trial is studying depression screening in patients undergoing radiation therapy for cancer.

DepressionUnspecified Adult Solid Tumor, Protocol Specific

Radiation Therapy Oncology Group463 participantsStarted May 2009

Alton, Illinois, United States • Grand Rapids, Michigan, United States • Grand Rapids, Michigan, United States +13 more locations

COMPLETEDPhase 183 miles

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00990054

The purpose of this research study is to determine if plerixafor can make cells more sensitive to killing by cytarabine and daunorubicin, an anti-cancer drug regimen referred to as "7+3" that is commonly used in treating acute myeloid leukemia (AML). In this study, plerixafor is used with treatments cytarabine and daunorubicin and with and without granulocyte-colony stimulating factor (GCSF). Subjects will be monitored to see how well they tolerate the use of these drugs together and how well they work to treat the leukemia. The purpose of the study is to determine the maximum tolerated dose (MTD) per plerixafor dosing schedule (once daily \[QD\] or twice daily \[BID\]), and/or recommended phase 2 dose (RP2D), by assessing safety and tolerability of plerixafor (Mozobil®) when used in combination with cytarabine and daunorubicin, and with and without granulocyte-colony stimulating factor (G-CSF)

Acute Myeloid Leukemia

Genzyme, a Sanofi Company36 participantsStarted Dec 2009

Duarte, California, United States • Boston, Massachusetts, United States • Ann Arbor, Michigan, United States +5 more locations

Depression Screening in Patients Undergoing Radiation Therapy For Cancer

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

Find Trials by Condition in Michigan

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Evaluation of the Spectra Optia PMN Cell Collection Procedure

Phase IIIB Subcutaneous Abatacept Monotherapy Study

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Dialysis Clinical Outcomes Revisited (DCOR) Trial

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Effects of HQK-1001 in Patients With Sickle Cell Disease

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Clinical Investigation of Expanded Designs of a Multifocal IOL

Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis

Randomized Study of Tauroursodeoxycholic Acid in Prophylactic Therapy of Total Parenteral Nutrition Associated Cholestasis in Infants

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme

Fibroid Ablation Study - Large Fibroids